First case of mirtazepine-induced Stevens-Johnson syndrome from India

A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhasin, Amit, Gurtoo, Anil, Gupta, Latika, Aggarwal, Gunjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480806/
https://www.ncbi.nlm.nih.gov/pubmed/23112435
http://dx.doi.org/10.4103/0253-7613.100411
Descripción
Sumario:A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.

Ejemplares similares